Júlia Companys-Alemany

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 5

Top Topics

Nitric Oxide Synthase

Duchenne Muscular Dystrophy

Top Venues

Pharmaceuticals (Basel, Switzerland)

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Aina Bellver-Sanchis, Bhanwar Singh Choudhary, Júlia Companys-Alemany, Sukanya, Pedro Antonio Ávila-López, Antón Leandro Martínez Rodríguez, Jose Manuel Brea Floriani, Ruchi Malik, Mercé Pallàs, Belén Pérez, Christian Griñán-Ferré
Structure-Based Virtual Screening and in vitro and in vivo Analyses Revealed Potent Methyltransferase G9a Inhibitors as Prospective Anti-Alzheimer's Agents. ChemMedChem 17 (13) (2022)
Foteini Vasilopoulou, Aina Bellver-Sanchis, Júlia Companys-Alemany, Júlia Jarne-Ferrer, Alba Irisarri, Verónica Palomera-Ávalos, Celia Gonzalez-Castillo, Daniel Ortuño-Sahagún, Coral Sanfeliu, Mercé Pallàs, Christian Griñán-Ferré
Cognitive Decline and BPSD Are Concomitant with Autophagic and Synaptic Deficits Associated with G9a Alterations in Aged SAMP8 Mice. Cells 11 (16) (2022)
Dolors Puigoriol-Illamola, Júlia Companys-Alemany, Kris McGuire, Natalie Z M Homer, Rosana Leiva, Santiago Vázquez, Damian J Mole, Christian Griñán-Ferré, Mercé Pallàs
Inhibition of 11β-HSD1 Ameliorates Cognition and Molecular Detrimental Changes after Chronic Mild Stress in SAMP8 Mice. Pharmaceuticals (Basel, Switzerland) 14 (10) (2021)
Christian Griñán-Ferré, Júlia Companys-Alemany, Júlia Jarné-Ferrer, Sandra Codony, Celia González-Castillo, Daniel Ortuño-Sahagún, Lluïsa Vilageliu, Daniel Grinberg, Santiago Vázquez, Mercé Pallàs
Inhibition of Soluble Epoxide Hydrolase Ameliorates Phenotype and Cognitive Abilities in a Murine Model of Niemann Pick Type C Disease. International journal of molecular sciences 22 (7) (2021)
Júlia Companys-Alemany, Andreea L Turcu, Aina Bellver-Sanchis, Maria I Loza, José M Brea, Anna M Canudas, Rosana Leiva, Santiago Vázquez, Mercé Pallàs, Christian Griñán-Ferré
A Novel NMDA Receptor Antagonist Protects against Cognitive Decline Presented by Senescent Mice. Pharmaceutics 12 (3) (2020)